BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Cyclacel Pharmaceuticals, Inc. 

200 Connell Drive
Suite 1500
Berkeley Heights  New Jersey  07922  U.S.A.
Phone: 908-517-7330 Fax: 866-271-3466


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
Cyclacel Pharmaceuticals, Inc. (CYCC) Reports First Quarter 2015 Financial Results 5/13/2015 10:48:56 AM
Cyclacel Pharmaceuticals, Inc. (CYCC) To Release First Quarter 2015 Financial Results 5/5/2015 10:13:58 AM
Cyclacel Pharmaceuticals, Inc. (CYCC)'s Second-Generation CDK2/9 Inhibitor, CYC065, Demonstrates Therapeutic Potential And Synergy With Other Anti-Cancer Compounds 4/20/2015 7:42:30 AM
Cyclacel Pharmaceuticals, Inc. (CYCC) Reports Fourth Quarter And Full Year 2014 Financial Results 3/25/2015 7:43:07 AM
Cyclacel Pharmaceuticals, Inc. (CYCC)'s CYC065 Featured In Presentations At The American Association for Cancer Research Annual Meeting 2015 3/20/2015 7:35:15 AM
Cyclacel Pharmaceuticals, Inc. (CYCC) To Release Fourth Quarter And Full Year 2014 Financial Results 3/18/2015 7:40:54 AM
Cyclacel Pharmaceuticals, Inc. (CYCC) Announces Pricing Of Public Offering Of Common Stock 3/4/2015 7:24:31 AM
Cyclacel Pharmaceuticals, Inc. (CYCC) To Present At The 17th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference 2/3/2015 8:44:12 AM
Cyclacel Pharmaceuticals, Inc. (CYCC) To Present At The Biotech Showcase 2015 Conference 1/6/2015 9:59:47 AM
Cyclacel Pharmaceuticals, Inc. (CYCC) Announces Enrollment Of 486 Patients, DSMB Recommendations And That The Seamless Phase 3 Trial Of Sapacitabine In AML Will Continue To Final Analysis 12/16/2014 7:38:08 AM
12345678910...